Baltimore, Maryland, United States Red Abbey Venture Partners appeared to be the VC, which was created in 2004. The main department of described VC is located in the Baltimore. The fund was located in North America if to be more exact in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. This Red Abbey Venture Partners works on 9 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2005. The top amount of exits for fund were in 2014. The fund is generally included in less than 2 deals every year.
We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Red Abbey Venture Partners, startups are often financed by Rho Ventures, MedImmune Ventures, MPM Capital. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Alta Partners, SV Health Investors. In the next rounds fund is usually obtained by InterWest Partners, TPG, Alta Partners.
Among the most popular portfolio startups of the fund, we may highlight Anacor Pharmaceutical, Nereus Pharmaceuticals, Oxagen. Among the most popular fund investment industries, there are Mobile, Health Care. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AVM Smartmoney | Switzerland, Zürich, Zurich |
| Blount Street Capital | - |
| Comporium | Rock Hill, South Carolina, United States |
| Greenbice | California, San Francisco, United States |
| Indus Valley Capital | Karachi, Pakistan, Sindh |
| InnoValley China | China, Hubei, Tianhe |
| Intervu | California, San Diego, United States |
| IPA4SME | - |
| Michigan Economic Development Corporation | Lansing, Michigan, United States |
| Mike Chalfen | - |
| Nordic Eye Venture Capital | Copenhagen, Denmark, Hovedstaden |
| Oregon Life Sciences | Eugene, Oregon, United States |
| Precedo Capital Group | Arizona, Paradise Valley, United States |
| Punk, Ziegel & Company | New York, New York, United States |
| Quaras | Japan, Tokyo |
| Rice Warner | - |
| Sensor Technology | Japan, Kanagawa Prefecture, Yokohama |
| Sparklab | Budapest, Hungary |
| United News of India | Delhi, India, New Delhi |
| Xircom | California, Thousand Oaks, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Perceiv AI | $1M | 08 Dec 2022 | Montréal, Quebec, Canada | ||
Cohero Health | $2M | 22 Dec 2015 | New York, New York, United States | ||
Atopix Therapeutics | $3M | 08 Oct 2014 | Vale of White Horse, England, United Kingdom | ||
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States | ||
Oxagen | $26M | 24 Nov 2009 | London, England, United Kingdom | ||
Corridor Pharmaceuticals | $10M | 02 Oct 2009 | Towson, Maryland, United States | ||
Corridor Pharmaceuticals | $2M | 23 Oct 2008 | Towson, Maryland, United States | ||
Stromedix | $25M | 21 Apr 2008 | Cambridge, Massachusetts, United States | ||
Advanced BioHealing | $25M | 27 Feb 2007 | Connecticut, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Perceiv AI | $1M | 08 Dec 2022 | Montréal, Quebec, Canada | ||
Cohero Health | $2M | 22 Dec 2015 | New York, New York, United States | ||
Atopix Therapeutics | $3M | 08 Oct 2014 | Vale of White Horse, England, United Kingdom | ||
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States | ||
Oxagen | $26M | 24 Nov 2009 | London, England, United Kingdom | ||
Corridor Pharmaceuticals | $10M | 02 Oct 2009 | Towson, Maryland, United States | ||
Corridor Pharmaceuticals | $2M | 23 Oct 2008 | Towson, Maryland, United States | ||
Stromedix | $25M | 21 Apr 2008 | Cambridge, Massachusetts, United States | ||
Advanced BioHealing | $25M | 27 Feb 2007 | Connecticut, United States |
